Home » Authors » Tiffany Turner

Tiffany Turner

Articles

ARTICLES

Middlebrook Gets $100M and a New Management Team

Nov. 1, 2011

By Tiffany Turner

No Abstract

IDM Pleased with Data from Osteosarcoma Program

Nov. 1, 2011

By Tiffany Turner

No Abstract

LigoCyte Sets Series C Terms: $28M for Vaccine Development

Nov. 1, 2011

By Tiffany Turner

No Abstract

NewCo News: Cortria Aims to Capitalize on Dyslipidemia Market

July 21, 2008

By Tiffany Turner

BioAlliance Stops Doxorubicin Trial After Pulmonary Reactions

July 17, 2008

By Tiffany Turner

Avastin, Tarceva Sales Boost Genentech's Quarterly Earnings

July 16, 2008

By Tiffany Turner

Neurogen Halts Dosing of Adipiplon in Insomnia

July 15, 2008

By Tiffany Turner

Big Pharmas Team Up to Link Technology and Business Needs

July 11, 2008

By Tiffany Turner

SGX Shares Soar on Merger Giving Lilly Technology Boost

July 10, 2008

By Tiffany Turner

Seattle Genetics Nets $4M in Deal with Daiichi Sankyo

July 9, 2008

By Tiffany Turner

View All Articles by Tiffany Turner

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...